ProTECT—Prediction of T-Cell Epitopes for Cancer Therapy
Somatic mutations in cancers affecting protein coding genes can give rise to potentially therapeutic neoepitopes. These neoepitopes can guide Adoptive Cell Therapies and Peptide- and RNA-based Neoepitope Vaccines to selectively target tumor cells using autologous patient cytotoxic T-cells. Currently...
Main Authors: | Arjun A. Rao, Ada A. Madejska, Jacob Pfeil, Benedict Paten, Sofie R. Salama, David Haussler |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-11-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2020.483296/full |
Similar Items
-
A Recurrent Mutation in Anaplastic Lymphoma Kinase with Distinct Neoepitope Conformations
by: Jugmohit S. Toor, et al.
Published: (2018-01-01) -
SIGANEO: Similarity network with GAN enhancement for immunogenic neoepitope prediction
by: Yilin Ye, et al.
Published: (2023-01-01) -
Predicting T cell recognition of MHC class I restricted neoepitopes
by: Zeynep Koşaloğlu-Yalçın, et al.
Published: (2018-11-01) -
Machine Learning for Cancer Immunotherapies Based on Epitope Recognition by T Cell Receptors
by: Anja Mösch, et al.
Published: (2019-11-01) -
Burden of tumor mutations, neoepitopes, and other variants are weak predictors of cancer immunotherapy response and overall survival
by: Mary A. Wood, et al.
Published: (2020-03-01)